Hypoglycemia in everyday life after gastric bypass and duodenal switch

European Journal of Endocrinology

Volumn 173, Issue 1, 2015, Pages 91-100

  Abrahamsson, Niclas ^a   Engström, Britt Edén ^a   Sundbom, Magnus ^a   Karlsson, F Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPOGLYCEMIA; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH BYPASS; WEIGHT REDUCTION; AGED; BLOOD; BLOOD PRESSURE MONITORING; DUODENUM; EATING; GASTROINTESTINAL ENDOSCOPY; HOMEOSTASIS; MEDICAL RECORD; METABOLISM; MIDDLE AGED; OBESITY; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE MONITORING, AMBULATORY; DIET RECORDS; DUODENUM; EATING; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC BYPASS; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 84935093730     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0821     Document Type: Article

References (56)

1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K & Schoelles K. Bari-atric surgery: a systematic review and meta-analysis. Journal of the American Medical Association 2004 292 1724-1737. (doi:10.1001/jama.292.14.1724)
2. Hedberg J & Sundbom M. Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass - a randomized controlled trial. Surgery for Obesity and Related Diseases 2012 8 338-345. (doi:10.1016/j.soard.2012.01.014)
3. Patti ME & Goldfine AB. Hypoglycemia after GBP: the dark side of GLP-1. Gastroenterology 2014 146 605-608. (doi:10.1053/j.gastro.2014.01.038)
4. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ & Patti ME. Patients with neuroglycopenia after GBP Surgery have exaggerated incretin and insulin secretory responses to a mixed meal. Journal of Clinical Endocrinology and Metabolism 2007 92 4678-4685. (doi:10.1210/jc.2007-0918)
5. Marsk R, Jonas E, Rasmussen F & Näslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 2010 53 2307-2311. (doi:10.1007/s00125-010-1798-5)
6. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V et al. Servere hypoglycemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005 48 2236-2240. (doi:10.1007/s00125-005-1933-x)
7. Lee CJ, Brown T, Magnuson TH, Egan JM, Carlson O & Elahi D. Hormonal response to a mixed-meal challenge after reversal of GBP for hypoglycemia. Journal of Clinical Endocrinology and Metabolism 2013 98 E1208-E1212. (doi:10.1210/jc.2013-1151)
8. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML &Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after GBP surgery. New England Journal of Medicine 2005 353 249-254. (doi:10.1056/NEJMoa043690)
9. Meier JJ, Butler AE, Galasso R & Butler PC. Hyperinsulinemic hypoglycemia after GBP surgery is not accompanied by islet hyperplasia or increased (β)-cell turnover. Diabetes Care 2006 29 1554-1559. (doi:10.2337/dc06-0392)
10. Reubi JC, Perren A, Rehmann R, Waser B, Christ E, Callery M, Goldfine AB & Patti ME. Glukagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinemic hypoglycemia following GBP. Diabetologia 2010 53 2641-2645. (doi:10.1007/s00125-010-1901-y)
11. Salehi M, Prigeon RL & D'Alessio DA. GBP surgery enhances GLP-1-stimulated postprandial insulin secretion in humans. Diabetes 2011 60 2308-2314. (doi:10.2337/db11-0203)
12. Salehi M, Gastadelli A & D'Alessio DA. Blockade of GLP-1 receptor corrects postprandial hypoglycemia after GBP. Gastroenterology 2014 146 669-680. (doi:10.1053/j.gastro.2013.11.044)
13. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S & Ismail-Beigi F. Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine 2008 358 2545-2559. (doi:10.1056/NEJMoa0802743)
14. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP & Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. Journal of the American Medical Association 2009 301 1565-1572. (doi:10.1001/jama.2009.460)
15. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T & Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Current Medical Research and Opinion 2005 21 1477-1483. (doi:10.1185/030079905X61929)
16. Redelmeier DA, Kenshole AB & Ray JG. Motor vehicle crashes in diabetic patients with tight glycemic control: a population-based case Control analysis. PLoS Medicine 2009 6 e1000192. (doi:10.1371/journal.pmed.1000192)
17. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM & Hunt SC. Long-term mortality after gastric bypass surgery. New England Journal of Medicine 2007 357 753-761. (doi:10.1056/NEJMoa066603)
18. Ritz P, Vaurs C, Bertrand M, Anduze Y, Guillame E & Hanaire H. Usefullness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous monitoring. Diabetes Technology & Therapeutics 2012 14 736-740. (doi:10.1089/dia.2011.0302)
19. Hanaire H, Bertrand M, Guerzi B, Anduze Y, Guillame E & Ritz P. High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass. Diabetes Technology & Therapeutics 2011 13 625-630. (doi:10.1089/dia.2010.0203)
20. Halperin F, Patti ME, Skow M, Bajwa M & Goldfine AB. Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. Journal of Obesity 2011 2011 869536. (doi:10.1155/2011/869536)
21. Johansson HE, Haenni A, Karlsson FA, Edén-Engström B, Ohrvall M, Sundbom M & Zethelius B. Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obesity Surgery 2010 20 549-558. (doi:10.1007/s11695-010-0102-6)
22. Roslin MS, Dudiy Y, Brownlee A, Weiskopf J & Shah P. Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch. Surgical Endoscopy 2014 28 91-99. (doi:10.1007/s00464-013-3176-0)
23. Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G & Ferrannini E. β-cell function in morbidly obese subjects during free living. Diabetes 2005 54 2382-2389. (doi:10.2337/diabetes.54.8.2382)
24. Nadelson J & Epstein A. A rare case of noninsulinoma pancreatogenous hypoglycemia syndrome. Gastrointestinal Medicine 2012 2012 164305. (doi:10.1155/2012/164305)
25. Valderas JP, Ahuad J, Rubio L, Escalona M, Pollak F & Maiz A. Acarbose improves hypoglycaemia following gastric bypas surgery without increasing glucagon-like peptide 1 level. Obesity Surgery 2012 22 582-586. (doi:10.1007/s11695-011-0581-0)
26. Moreira RO, Moreira RB, Machado NA, Gonçalves TB & Coutinho WF. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obesity Surgery 2008 18 1618-1621. (doi:10.1007/s11695-008-9569-9)
27. Myint KS, Greenfield JR, Farooqi IS, Henning E, Holst JJ & Finer N. Prolonged successful therapy for hyperinsulinemic hypoglycemia after gastric bypass: the pathophysiological role of GLP-1 and its response to a somatostatin analogue. European Journal of Endocrinology 2012 166 951-955. (doi:10.1530/EJE-11-1065)
28. de Heide LJ, Laskewitz AJ & Apers JA. Treatment of severe postRGBP hyperinsulinemic hypoglycemia with pasireotide: a comparison with octreotide on insulin, glucagon, and GLP-1. Surgery for Obesity and Related Diseases 2014 10 e31-e33. (doi:10.1016/j.soard.2013.11.006)
29. Gonzalez-Gonzalez A, Delgado M & Fraga-Fuentes MD. Use of diazoxide in management of severe postprandial hypoglycemia in patient after Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases 2013 9 e18-e19. (doi:10.1016/j.soard.2011.05.010)
30. Yunfeng C & Elahi A. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Journal of Gastrointestinal Surgery 2011 15 1879-1888. (doi:10.1007/s11605-011-1585-8)
31. Halperin F, Patti ME & Goldfine AB. Glucagon treatment for post-gastric bypass hypoglycemia. Obesity 2010 18 1858-1860. (doi:10.1038/oby.2010.15)
32. Abrahamsson N, Eden Engström B, Sundbom M & Karlsson FA. GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication? European Journal of Endocrinology 2013 169 885-889. (doi:10.1530/EJE-13-0504)
33. Monnier L & Colette C. Target for glycemic control. Diabetes Care 2009 32 S199-S204. (doi:10.2337/dc09-S310)
34. McAulay V, Deary IJ & Frier BM. Symptoms of hypoglycemia in people with diabetes. Diabetic Medicine 2001 18 690-705. (doi:10.1046/j.1464-5491.2001.00620.x)
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF &Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
36. McDonell CM, Donath SM, Vidmar SI, Werther GA & Cameron FJ. A novel approach to continouos glucose analysis utilizing glycemic variation. Diabetes Technology & Therapeutics 2005 7 253-263. (doi:10.1089/dia.2005.7.253)
37. Cameron FJ, Donath SM & Baghurst PA. Measuring glycemic variation. Current Diabetes Reviews 2010 6 17-26. (doi:10.2174/157339910790442592)
38. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC &Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970 19 644-655. (doi:10.2337/diab.19.9.644)
39. Baek YH, Jin HY, Lee KA, Kang SM, Kim WJ, Kim MG, Park JH, Chae SW, Baek HS & Park TS. The correlation and accuracy of glucose levels between interstitial fluid and venous plasma by continuous glucose monitoring system. Korean Diabetes Journal 2010 34 350-358. (doi:10.4093/kdj.2010.34.6.350)
40. Juvenile Diabetes Research Foundation Continouos Glucose Monitoring Study Group, Fox LA, Beck RW & Xing D. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010 33 1297-1299. (doi:10.2337/dc09-1971)
41. Steil GM, Rebrin K, Mastrototaro J, Bernaba B & Saad MF. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technology & Therapeutics 2003 5 27-31. (doi:10.1089/152091503763816436)
42. Steil GM, Rebrin K, Harari F, Jinagonda S, Tadros S, Darwin C &Saad MF. Interstitial fluid glucose dynamics during insulin-induced hypoglycemia. Diabetologia 2005 48 1833-1840. (doi:10.1007/s00125-005-1852-x)
43. Boyne MS, Silver DM, Kaplan J & Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003 52 2790-2794. (doi:10.2337/diabetes.52.11.2790)
44. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005 28 1245-1249. (doi:10.2337/diacare.28.5.1245)
45. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P & Gerich J. Hierarchy of glycemic thresholds for counter-regulatory hormone secretion, symptoms, and cerebral dysfunction. American Journal of Physiology 1991 260 E67-E74.
46. Schwartz NS, Clutter WE, Shah SD & Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. Journal of Clinical Investigation 1987 79 777-781. (doi:10.1172/JCI112884)
47. Graveling AJ, Deary IJ & Frier BM. Acute hypoglycemia impairs executive cognitive function in adults with and without type 1 diabetes. Diabetes Care 2013 36 3240-3246. (doi:10.2337/dc13-0194)
48. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenz A, Annibale B, Lepore M, Lalli C et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 1994 37 797-807. (doi:10.1007/BF00404337)
49. Heller SR & Cryer PE. Reduced neuroendocrine and symptomatic responses to sub-sequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991 40 223-226. (doi:10.2337/diab.40.2.223)
50. Veneman T, Mitrakou A, Mokan M, Cryer P & Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993 42 1233-1237. (doi:10.2337/diab.42.9.1233)
51. Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S &Cryer PE. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes 1998 47 1920-1927. (doi:10.2337/diabetes.47.12.1920)
52. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA & Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycemia. PNAS 1994 91 9352-9356. (doi:10.1073/pnas.91.20.9352)
53. Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ & Smith QR. Blood-brain barrier glucose transporter effects of hypo- and hyperglycemia revisited. Journal of Neurochemistry 1999 72 238-247. (doi:10.1046/j.1471-4159.1999.0720238.x)
54. Mastaitis JW, Wurmbach E, Cheng H, Sealfon SC & Mobbs CV. Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes 2005 54 952-958. (doi:10.2337/diabetes.54.4.952)
55. Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G &Ferrannini E. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and b cell function. Diabetologia 2006 49 2136-2143. (doi:10.1007/s00125-006-0337-x)
56. Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G & Ferrannini E. β-cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 2005 54 2382-2389. (doi:10.2337/diabetes.54.8.2382)